AzTrials
AzTrials

Stress Disorders, Post-TraumaticNeuroPsy RéaNCT01838798

Neuropsychological Impact of Hospitalization on Intubated, Ventilated and Sedated ICU Patients

A study testing Baseline activities, Clinical interview with a psychologist and Telephone interview 2 months after ICU discharge in people with Stress Disorders, Post-Traumatic and Depression, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a prospective, single-center, pilot, cohort study. The first phase of this study is observational and the usual care of patients is maintained during the ICU stay, except for an interview with a psychologist preceding patient discharge. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stress Disorders, Post-Traumatic, Depression
What is being tested?
Baseline activities, Clinical interview with a psychologist and Telephone interview 2 months after ICU discharge
Could I receive a placebo?
No, everyone receives an active treatment
How many people
125 participants
Where
1 siteFrance
Study dates
Nov 2013to Oct 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The patient (or his/her "trusted person") must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for a telephone interview at 2 months after ICU discharge, and for a follow-up visit at 4 months after ICU discharge
  • Patient admitted to the ICU and intubated and ventilated for at least 48 hours

Who cannot join

  • The patient is currently participating in or has participated in another study (within the past 3 months) that might influence the results of the current study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The patient is pregnant, parturient, or breastfeeding
  • The patient has a contra-indication for a treatment used in this study
Show all 16Show fewer
  • Patient admitted to intensive care with sedation started for more than 24 hours
  • Patient with neurological or psychiatric (cognitive) disorders
  • Patient admitted for cardiac arrest
  • Patient admitted for stroke
  • Patient admitted for cervical trauma > C6
  • Patient presenting with tracheotomy accompanied by long-term mechanical ventilation
  • Moribund patient or with little hope of survival beyond 48 hours
  • Patients for whom a limitation or termination of care is considered
  • McCabe Score = 0
  • Knauss Scale = C or D

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de Nîmes - Hôpital Universitaire Carémeau

    Nîmes, 30029

Other trials in France

About this study

This is a prospective, single-center, pilot, cohort study. The first phase of this study is observational and the usual care of patients is maintained during the ICU stay, except for an interview with a psychologist preceding patient discharge. A phone interview at 2 months and a visit with a psychologist at four months after ICU discharge are specific to the study.

The main objective of this study is to make a first estimate of the percentage of patients (CI = +- 10%) with cognitive impairment at four months after ICU discharge. The presence / absence of cognitive impairment will be determined by the D2 test.

Read the detailed description

The secondary objectives of this study are:

  1. To study the potential links between cognitive impairment and quality of life 4 months after discharge from the Intensive Care Unit.
  2. To study the associations between variables measured during hospitalization. Is there "clustering" among certain symptoms during hospitalization?
  3. To study the associations between variables measured at two and four months after ICU discharge. Is there clustering among these symptoms?
  4. To study potential risk factors for cognitive problems at 4 months after ICU discharge.
  5. If objective C determines the presence of clusters, is the presence / absence of these clusters related to the variables (or clusters of variables) measured during hospitalization?
  6. To study potential risk factors for poor quality of life at 4 months:
Being tested
Baseline activities, Clinical interview with a psychologist, Telephone interview 2 months after ICU discharge
Keywords
cognitive disorders, quality of life, Intensive care
Medical subject headings
Stress Disorders, Post-Traumatic, Depression, Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Baseline activitiesOther

    Initial consent procedures and baseline data collection.

  • Clinical interview with a psychologistOther

    Clinical interview with a psychologist.

    This interview with a psychologist will take place after patient consent procedures, and at least 2 days after discontinuation of sedation, and before leaving the ICU. This interview will include:

    • An inventory of peritraumatic distress symptoms
    • A questionnaire on peritraumatic dissociative experiences
    • An assessment of related, potential impacts
    • The HADS questionnaire
  • Telephone interview 2 months after ICU dischargeOther

    At 2 months after leaving the ICU, a psychologist will contact the patient with questions regarding his/her representation of hospitalization. This implies the following:

    • Questionnaires assessing memories and stressors (Questionnaires ICUMT, and ICU-SEQ
    • An assessment of psychological trauma
    • An assessment of potential impacts
  • Clinical interview with a psychologistOther

    At 4 months after ICU discharge, the patient has a clinical interview during which a psychologist will:

    • assess cognitive functions
    • evaluate clinical symptoms of depression
    • assess quality of life
    • assess symptoms of post traumatic stress
Study groups in NCT01838798
Study groupRoleWhat they receive
Study populationExperimentalSee in inclusion/exclusion criteria. Interventions: Baseline activities; Clinical interview with a psychologist; Telephone interview 2 months after ICU discharge; Clinical interview with a psychologist .
Receives: Other: Baseline activities; Other: Clinical interview with a psychologist; Other: Telephone interview 2 months after ICU discharge

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Presence/absence of cognitive impairment

    based on D2 test

    Measured: 4 months after ICU discharge

Secondary outcomes (23)
  1. Duration of sedation

    Measured: expected average of 48 hours

  2. Duration of ventilation

    Measured: expected average of 36 hours

  3. Daily average for RASS scale

    Measured: Expected maximum of 28 days

  4. Daily average for Behaviour pain scale

    Measured: expected average of 48 hours

  5. CAM ICU score

    Measured: upon awakening (expected average of 48 hours)

  6. Peritraumatic distress inventory

    Measured: expected average of 5 days (end of ICU stay)

  7. Questionnaire PDEQ-10

    Measured: expected average of 5 days (end of ICU stay)

  8. Assessment of potential impacts

    Measured: expected average of 5 days (end of ICU stay)

  9. HADS score

    Measured: expected average of 5 days (end of ICU stay)

  10. ICUMT questionnaire

    Measured: 60 +- 3 days after ICU discharge

  11. ICU-SEQ questionnaire

    Measured: 60 +- 3 days after ICU discharge

  12. Assessment of psychotramatisme

    Measured: 60 +- 3 days after ICU discharge

  13. HADS score

    Measured: 60 +- 3 days after ICU discharge

  14. PCLS scale (DSM IV items)

    Measured: 4 months after ICU discharge

  15. IDS-C Questionnaire

    Measured: 4 months after ICU discharge

  16. SF-36

    Measured: 4 months after ICU discharge

  17. Forward span test

    Measured: 4 months after ICU discharge

  18. Backwards span test

    Measured: 4 months after ICU discharge

  19. Rey 15-word test

    Measured: 4 months after ICU discharge

  20. Test D2 (units = n)

    Measured: 4 months after ICU discharge

  21. Wisconsin test

    Measured: 4 months after ICU discharge

  22. Stroop test

    Measured: 4 months after ICU discharge

  23. Verbal fluency test

    Measured: 4 months after ICU discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Apr 2013 (estimated)
  2. Study startNov 2013
  3. Primary completionOct 2016
  4. Study completionOct 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
125 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01838798
Sponsor's protocol ID
LOCAL/2012/CR-02
Other IDs
2013-A00022-43
Acronym
NeuroPsy Réa
Status last verified
Oct 2016
First submitted
21 Apr 2013
Last updated
19 Dec 2025
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Baseline activities, Clinical interview with a psychologist and Telephone interview 2 months after ICU discharge in people with Stress Disorders, Post-Traumatic and Depression, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Presence/absence of cognitive impairment (time frame: 4 months after ICU discharge). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in